Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.11% | 28.49% | 32.52% | 34.14% | 41.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.11% | 28.49% | 32.52% | 34.14% | 41.71% |
| Cost of Revenue | 27.10% | 27.35% | 26.89% | 24.35% | 33.48% |
| Gross Profit | 27.12% | 28.70% | 33.58% | 36.06% | 43.32% |
| SG&A Expenses | 15.28% | 17.18% | 21.18% | 25.32% | 32.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.40% | 15.28% | 19.68% | 24.20% | 34.69% |
| Operating Income | 238.41% | 189.60% | 127.04% | 73.35% | 29.48% |
| Income Before Tax | 612.11% | 393.65% | 216.27% | 121.18% | 67.23% |
| Income Tax Expenses | 224.87% | 296.47% | 347.93% | 214.61% | 130.59% |
| Earnings from Continuing Operations | 522.69% | 352.96% | 200.86% | 114.63% | 63.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 522.69% | 352.96% | 200.86% | 114.63% | 63.92% |
| EBIT | 238.41% | 189.60% | 127.04% | 73.35% | 29.48% |
| EBITDA | 278.03% | 213.92% | 138.86% | 79.57% | 32.78% |
| EPS Basic | 514.98% | 345.49% | 199.09% | 114.08% | 65.18% |
| Normalized Basic EPS | 602.47% | 384.87% | 214.23% | 120.44% | 68.35% |
| EPS Diluted | 493.41% | 332.77% | 195.08% | 112.60% | 64.50% |
| Normalized Diluted EPS | 576.78% | 371.00% | 210.34% | 118.92% | 67.64% |
| Average Basic Shares Outstanding | 1.20% | 1.58% | 1.82% | 2.38% | 3.41% |
| Average Diluted Shares Outstanding | 3.09% | 2.96% | 2.54% | 2.46% | 2.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |